Inactivated Vaccine Market - Size, Share, Outlook, and Forecast till 2026

A vaccine that consists of virus particles, bacteria or other pathogens, which were grown in culture and then killed using heat or formaldehyde is called as inactivated vaccine or killed vaccine. The infectivity is reduced, as pathogens for inactivated vaccines are grown under controlled conditions and are killed. Inactivated vaccines are classified into whole virus vaccines, split virus vaccines, and subunit vaccines based on the method of inactivation of virus.

Increasing demand for inactivated vaccines from governments of industrialized and emerging economies is one of the major factors that is expected to drive growth of the global inactivated vaccines market over the forecast period. Moreover, advantages of inactivated vaccines such as safety, stability, and lack of chances of pathogen reactivation over live attenuated vaccines are expected to fuel growth of the global inactivated vaccines market during the forecast period. Rising prevalence of infectious diseases and increasing awareness among people about immunization are other factors propelling the market growth.

However, stringent government regulations and lack of supply of vaccines in remote areas are major factors that are expected to restrain growth of the global inactivated vaccines market.

Key Developments in Inactivated Vaccine Market

Key players are adopting various strategies such as mergers, acquisitions, new product launches, expansions, collaborations, partnerships, approvals, and joint ventures to retain its position in the inactivated vaccine market. In 2017, Seqirus, a leading innovator in influenza vaccines and pandemic preparedness, announced its next major advancement in the use of cell-based influenza vaccine technology at its state-of-the art manufacturing facility in Holly Springs, North Carolina.

Moreover, in August 2017, Seqirus launched a new influenza vaccine called FLUAD 1, which is an adjuvanted trivalent influenza vaccine (aTIV) developed to address the burden of influenza in adults aged 65 years and over.

In March 2018, Sanofi completed the acquisition of Bioverativ Inc, a global biotechnology company. Also, Fluzone QIV HD (Quadrivalent Inactivated Influenza Vaccine - High Dose) by Sanofi is currently in phase 111 clinical trial.

Some of the major players operating in the global inactivated vaccine market include Emergent BioSolutions, GlaxoSmithKline plc, Merck & Co., Inc., Seqirus, Sanofi, Valneva SE, Pfizer Inc., and Bharat Biotech among others.

Global Rabies Vaccine Sales Market Report 2017

Published Date : Oct 2017

In this report, the global Rabies Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Doses), reven...

Global Influenza Vaccine Sales Market Report 2017

Published Date : Oct 2017

In this report, the global Influenza Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Doses), re...

Global and Chinese Foot and Mouth Disease Vaccine Industry, 2017 Market Research Report

Published Date : Oct 2017

The 'Global and Chinese Foot and Mouth Disease Vaccine Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Foot and Mouth Disease Vaccine industry with a focus on the Chinese market. The report provides key statistics on the market stat...

United States Influenza Vaccine Market Report 2017

Published Date : Oct 2017

In this report, the United States Influenza Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions:...

United States Rabies Vaccine Market Report 2017

Published Date : Oct 2017

In this report, the United States Rabies Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: ...

Asia-Pacific Pertussis Vaccine Market Report 2017

Published Date : Oct 2017

In this report, the Asia-Pacific Pertussis Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (...

Asia-Pacific Meningococcal Infections Vaccine Market Report 2017

Published Date : Oct 2017

In this report, the Asia-Pacific Meningococcal Infections Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Region...

EMEA (Europe, Middle East and Africa) Hepatitis A Vaccine Market Report 2017

Published Date : Oct 2017

In this report, the EMEA Hepatitis A Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales ...

EMEA Vaccine Adjuvants Market by Manufacturers, Regions, Type and Application, Forecast to 2022

Published Date : Oct 2017

An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been ...

United States Newcastle Disease Vaccine Market by Manufacturers, States, Type and Application, Forecast to 2022

Published Date : Oct 2017

"Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans. Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens." ...

 

Select License :

  • Single User : $4500
  • Multiple User : $7000
  • Corporate User : $10000

Happy To Assist You

Assist you at Worldwide Market Reports

We will be happy to help you find what you need. Please call us or write to us:

Worldwide Market Reports Benefits

Custom Research Solution

Talk to our research consultant to design an exclusive report as per your research needs.

Customer Fulfilment

We aim to fulfil client's research demands with tailored research solutions.

Quick Turnaround Time Reports

We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

360-degree Approach

We cover each industry from supply and demand side with an aim to provide a most holistic research study.